Pro Medicus Ltd
ASX:PME
Pro Medicus Ltd
EPS (Diluted)
Pro Medicus Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pro Medicus Ltd
ASX:PME
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
38%
|
CAGR 5-Years
35%
|
CAGR 10-Years
41%
|
|
|
Mach7 Technologies Ltd
ASX:M7T
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-26%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
4DMedical Ltd
ASX:4DX
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
EPS (Diluted)
$0
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alcidion Group Ltd
ASX:ALC
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Singular Health Group Ltd
ASX:SHG
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pro Medicus Ltd
Glance View
Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments. The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.
See Also
What is Pro Medicus Ltd's EPS (Diluted)?
EPS (Diluted)
0.9
AUD
Based on the financial report for Dec 31, 2024, Pro Medicus Ltd's EPS (Diluted) amounts to 0.9 AUD.
What is Pro Medicus Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
41%
Over the last year, the EPS (Diluted) growth was 40%. The average annual EPS (Diluted) growth rates for Pro Medicus Ltd have been 38% over the past three years , 35% over the past five years , and 41% over the past ten years .
You don't have any saved screeners yet